US Patent Issued to Atai Therapeutics on Sept. 8 for "Crystalline forms of N,N-dimethyltryptamine and methods of using the same" (American, German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,182, issued on Sept. 8, was assigned to Atai Therapeutics Inc. (New York).

"Crystalline forms of N,N-dimethyltryptamine and methods of using the same" was invented by Majed Fawaz (Foxborough, Mass.) and Setu Kasera (Stuttgart, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides crystalline forms of N,N-dimethyltryptamine,Also provided herein are methods of using crystalline forms of N,N-DMT and compositions comprising the same, e.g., in the treatment of mental health diseases and/or disorders."

The patent was filed on Dec. 1, 2023, under Application No. 18/526,500.

*For further information, including images, char...